Feng et al. demonstrated that GPR81 enhances lung cancer cells’ sensitivity to chemotherapy and counteracts immune evasion through the upregulation of checkpoint ligands like PD-L1 [32]. This evidence concerns the gene HCAR1 and lung carcinoma.